Does ALMOTRIPTAN Cause Maternal exposure during pregnancy? 20 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Maternal exposure during pregnancy have been filed in association with ALMOTRIPTAN. This represents 7.2% of all adverse event reports for ALMOTRIPTAN.
20
Reports of Maternal exposure during pregnancy with ALMOTRIPTAN
7.2%
of all ALMOTRIPTAN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From ALMOTRIPTAN?
Of the 20 reports, 6 (30.0%) required hospitalization.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALMOTRIPTAN. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does ALMOTRIPTAN Cause?
Drug ineffective (125)
Hyperhidrosis (114)
Off label use (114)
Product use in unapproved indication (104)
Nightmare (101)
Sedation (101)
Nausea (61)
Nephrolithiasis (44)
Headache (27)
Migraine (21)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which ALMOTRIPTAN Alternatives Have Lower Maternal exposure during pregnancy Risk?
ALMOTRIPTAN vs ALMOTRIPTAN MALATE
ALMOTRIPTAN vs ALOE VERA LEAF
ALMOTRIPTAN vs ALOGLIPTIN
ALMOTRIPTAN vs ALOGLIPTIN\METFORMIN
ALMOTRIPTAN vs ALOGLIPTIN\PIOGLITAZONE